Eric M. Stone is a board member, advisor, entrepreneur, investor and CEO in the Life Sciences industry. A patient advocate and serial healthcare entrepreneur, Stone currently serves as National Trustee and a Committee Chair of the Crohn’s and Colitis Foundation of America (CCFA). He served as Vice President of Sales and Marketing for Molecular Health, and earlier in his career launched a series of pioneering interventional cardiology devices for Abbott while based in Brussels, Belgium and California. Stone was a founding member of Model N’s (NYSE: MODN) Life Sciences division, where he led marketing and business development. Stone began his career in Marketing with Trilogy Software, and has since co-founded social sector programs at Harvard and Wharton. He also co-founded Velano Vascular which was acquired by Becton Dickinson in 2021. He served for a decade on Harvard University’s Alumni Association (HAA) Board of Directors. Stone is a Director of Vigilant Biosciences and an Advisor to multiple healthcare upstarts. Stone received an MBA from The Wharton School, a Master’s from Harvard University, and a BA from the University of Pennsylvania. He lives with his wife and daughter in San Francisco.

Eric was featured as the Healthtech Leader of the Month in May 2022.